Myriad Genetics Inc (0K3W)
LSE
Year End December 30 2023 | 2017 | 2018 | 2019 | 2020 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 771.4M | 772.6M | 851.1M | 641.4M | 299.8M | 690.6M | 678.4M | 753.2M |
Operating Income | 49.4M | 57.5M | 7.6M | -231.7M | -87.8M | -190.5M | -140.6M | -257.4M |
Pre Tax Income | 42.9M | 116.9M | 0 | -223.3M | -94.1M | -57.1M | -140.6M | -262.2M |
Net Income | 21.8M | 131.1M | 4.6M | -199.5M | -53.1M | -27.2M | -112M | -263.3M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | 0.319 | 1.857 | 0.063 | -2.671 | -0.704 | -0.34 | -1.379 | -3.203 |
EBIT | 47.7M | 118.3M | 8.8M | -215.5M | -89M | -51.2M | -140M | -261.8M |
EBITDA | 97.7M | 111.8M | 80.6M | -60M | -52M | -125.9M | -71M | -195.5M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.